| CYVNY |
Ceryvyn Therapeutics Ltd. - Unsponsored ADR |
524.83m |
0.02 |
0.00% |
0.00 |
(89,724.18%) |
— |
— |
| PROK |
ProKidney Corp. |
513.95m |
1.60 |
(4.76%) |
0.00 |
(10,288.39%) |
— |
— |
| AUTL |
Autolus Therapeutics PLC Sponsored ADR |
513.69m |
1.86 |
(2.62%) |
0.00 |
(238.66%) |
193.29% |
22.22% |
| ARVN |
Arvinas, Inc. |
509.36m |
7.59 |
(2.70%) |
58.31 |
2.94% |
(15.05%) |
— |
| CAPR |
Capricor Therapeutics, Inc. |
508.72m |
8.36 |
(2.45%) |
0.00 |
0.00% |
(11.55%) |
— |
| PBYI |
Puma Biotechnology, Inc. |
506.91m |
9.77 |
(0.41%) |
18.11 |
11.55% |
(2.86%) |
— |
| RGNX |
REGENXBIO Inc. |
487.84m |
7.40 |
2.21% |
0.00 |
(112.58%) |
12.00% |
— |
| OVID |
Ovid Therapeutics |
487.27m |
2.40 |
(4.00%) |
0.00 |
(439.11%) |
1,333.39% |
— |
| ENTX |
Entera Bio Ltd. |
486.74m |
2.75 |
(1.79%) |
0.00 |
0.00% |
66.42% |
— |
| ASMB |
Assembly Biosciences, Inc. |
481.73m |
23.67 |
0.04% |
23.21 |
(0.06%) |
125.12% |
— |
| TECX |
Tectonic Therapeutic, Inc. |
471.53m |
23.67 |
(1.87%) |
0.00 |
0.00% |
— |
— |
| CTNM |
Contineum Therapeutics, Inc. |
469.89m |
12.56 |
0.56% |
0.00 |
0.00% |
— |
— |
| CYPH |
Cypherpunk Technologies Inc. |
440.76m |
4.12 |
0.98% |
6.98 |
0.00% |
0.00% |
— |
| KYTX |
Kyverna Therapeutics, Inc. |
432.29m |
6.81 |
(2.58%) |
0.00 |
0.00% |
— |
— |
| EDIT |
Editas Medicine, Inc. |
430.03m |
2.58 |
(6.18%) |
0.00 |
(157.32%) |
20.83% |
— |
| PRTA |
Prothena Corporation plc |
427.12m |
8.29 |
(0.36%) |
0.00 |
(80.67%) |
427.32% |
— |
| PRTCY |
PureTech Health PLC Sponsored ADR |
424.00m |
15.39 |
1.58% |
0.00 |
(199.36%) |
28.48% |
— |
| DMAC |
DiaMedica Therapeutics, Inc. |
422.24m |
7.94 |
1.40% |
0.00 |
0.00% |
— |
— |
| AVIR |
Atea Pharmaceuticals, Inc. |
414.66m |
5.17 |
0.00% |
0.00 |
0.00% |
— |
— |
| SPRY |
ARS Pharmaceuticals, Inc. |
412.71m |
4.08 |
(1.69%) |
0.00 |
(184.26%) |
4.08% |
— |
| ARCT |
Arcturus Therapeutics Holdings Inc. |
412.41m |
13.85 |
(1.91%) |
0.00 |
(317.61%) |
(75.95%) |
— |
| RLMD |
Relmada Therapeutics, Inc. |
406.41m |
3.83 |
0.52% |
0.00 |
0.00% |
— |
— |
| IRD |
Opus Genetics, Inc. |
405.16m |
4.76 |
(2.26%) |
0.00 |
(1,091.82%) |
(36.09%) |
— |
| GALT |
Galectin Therapeutics Inc. |
399.36m |
3.90 |
(1.52%) |
0.00 |
0.00% |
— |
— |
| ZURA |
Zura Bio Limited |
398.65m |
4.04 |
(2.88%) |
0.00 |
0.00% |
— |
— |
| TTRX |
Turn Therapeutics Inc. |
394.99m |
12.49 |
(7.16%) |
0.00 |
0.00% |
— |
— |
| SRZN |
Surrozen, Inc. |
386.57m |
29.54 |
(12.29%) |
0.00 |
(2,887.07%) |
(8.79%) |
— |
| RZLT |
Rezolute, Inc. |
379.39m |
3.90 |
(1.02%) |
0.00 |
0.00% |
— |
— |
| AGEN |
Agenus Inc. |
375.30m |
8.54 |
0.47% |
3.23 |
69.18% |
30.47% |
— |
| CABA |
Cabaletta Bio, Inc. |
373.00m |
2.07 |
(4.17%) |
0.00 |
0.00% |
— |
— |
| CCCC |
C4 Therapeutics, Inc. |
372.77m |
2.98 |
(1.65%) |
0.00 |
(289.44%) |
2.33% |
— |
| FENC |
Adherex Technologies Inc. |
372.41m |
10.61 |
(0.09%) |
0.00 |
(5.49%) |
77.83% |
— |
| ARTV |
Artiva Biotherapeutics, Inc. |
366.19m |
6.99 |
(6.68%) |
0.00 |
0.00% |
— |
— |
| OBIO |
Orchestra BioMed Holdings, Inc. |
366.04m |
5.95 |
0.00% |
0.00 |
(186.30%) |
986.14% |
— |
| ENTA |
Enanta Pharmaceuticals, Inc. |
349.50m |
11.88 |
(1.00%) |
0.00 |
(96.89%) |
0.70% |
— |
| LRMR |
Larimar Therapeutics, Inc. |
344.89m |
3.08 |
(7.23%) |
0.00 |
0.00% |
— |
— |
| OCGN |
Ocugen, Inc. |
339.11m |
1.02 |
2.00% |
0.00 |
(1,786.27%) |
(3.66%) |
— |
| BNTC |
Benitec Biopharma Limited |
336.24m |
9.59 |
(0.52%) |
0.00 |
0.00% |
(1.32%) |
— |
| YDES |
YD Bio Limited |
332.25m |
5.73 |
20.13% |
— |
— |
— |
— |
| EYPT |
EyePoint, Inc. |
324.15m |
3.62 |
(0.82%) |
0.00 |
(10,998.67%) |
(94.63%) |
1.26% |
| BBOT |
BridgeBio Oncology Therapeutics, Inc |
319.90m |
3.95 |
(1.00%) |
0.00 |
0.00% |
— |
— |
| PRLD |
Prelude Therapeutics Incorporated |
318.42m |
3.88 |
(2.76%) |
0.00 |
(269.75%) |
— |
— |
| EVMN |
Evommune Inc. |
309.93m |
8.49 |
(3.75%) |
0.00 |
0.00% |
— |
— |
| IPSC |
Century Therapeutics, Inc. |
306.02m |
1.67 |
(1.18%) |
0.00 |
0.00% |
8,286.72% |
— |
| SABS |
SAB Biotherapeutics, Inc. |
304.80m |
3.29 |
(1.79%) |
0.00 |
0.00% |
(60.26%) |
— |
| ABEO |
Abeona Therapeutics Inc. |
303.77m |
5.40 |
(0.55%) |
0.00 |
(242.62%) |
427.47% |
— |
| VNDA |
Vanda Pharmaceuticals Inc. |
301.10m |
5.05 |
1.81% |
0.00 |
(127.41%) |
6.02% |
— |
| RCKT |
Rocket Pharmaceuticals, Inc. |
300.78m |
2.60 |
(3.35%) |
0.00 |
0.00% |
— |
— |
| XFOR |
X4 Pharmaceuticals, Inc. |
297.44m |
3.01 |
0.33% |
0.00 |
(568.80%) |
(51.65%) |
— |
| IKT |
Inhibikase Therapeutics, Inc. |
293.03m |
2.06 |
(1.90%) |
0.00 |
0.00% |
110.93% |
— |
| FULC |
Fulcrum Therapeutics, Inc. |
288.79m |
3.74 |
(1.32%) |
0.00 |
0.00% |
1,939.80% |
— |
| IFRX |
InflaRx N.V. |
284.42m |
1.89 |
(2.07%) |
0.00 |
0.00% |
(83.39%) |
— |
| UPB |
Upstream Bio, Inc. |
283.17m |
5.36 |
3.68% |
0.00 |
(4,955.67%) |
15.98% |
— |
| QTTB |
Q32 Bio Inc. |
282.81m |
8.77 |
(4.88%) |
2.90 |
0.00% |
(307.33%) |
— |
| IMRX |
Immuneering Corporation |
280.79m |
4.27 |
(1.61%) |
0.00 |
0.00% |
(84.76%) |
— |
| FATE |
Fate Therapeutics, Inc. |
279.18m |
2.35 |
0.86% |
0.00 |
(1,941.09%) |
(23.36%) |
— |
| LXEO |
Lexeo Therapeutics, Inc. |
278.28m |
3.31 |
(2.36%) |
0.00 |
0.00% |
— |
— |
| IVVD |
Invivyd, Inc. |
274.12m |
0.93 |
2.20% |
0.00 |
(183.90%) |
26.30% |
— |
| PALI |
Palisade Bio, Inc. |
273.60m |
1.45 |
(7.64%) |
2.24 |
(4,230.60%) |
5,492.59% |
— |
| GLSI |
Greenwich LifeSciences, Inc. |
265.68m |
18.22 |
0.66% |
0.00 |
0.00% |
— |
— |
| STRO |
Sutro Biopharma, Inc. |
260.49m |
15.98 |
1.72% |
0.00 |
(395.25%) |
(56.25%) |
— |
| ZNTL |
Zentalis Pharmaceuticals, Inc. |
260.35m |
2.70 |
(1.82%) |
0.00 |
0.00% |
— |
— |
| PYXS |
Pyxis Oncology, Inc. |
250.22m |
2.86 |
(2.05%) |
0.00 |
0.00% |
— |
— |
| ACIU |
AC Immune |
249.35m |
2.52 |
(5.26%) |
0.00 |
(1,783.66%) |
(85.56%) |
— |
| LYEL |
Lyell Immunopharma, Inc. |
247.99m |
9.85 |
(2.67%) |
0.00 |
(920,285.19%) |
(55.00%) |
— |
| YARW |
Yarrow Bioscience, Inc |
246.04m |
25.54 |
(3.03%) |
0.00 |
(3,881.54%) |
1.26% |
— |
| TRDA |
Entrada Therapeutics, Inc. |
242.19m |
6.16 |
(0.96%) |
0.00 |
(3,537.73%) |
(94.10%) |
— |
| MGNX |
MacroGenics, Inc. |
242.06m |
3.74 |
(1.58%) |
0.00 |
(7.97%) |
21.93% |
— |
| SION |
Sionna Therapeutics, Inc. |
241.89m |
5.23 |
0.00% |
0.00 |
0.00% |
— |
— |
| CAMP |
CAMP4 Therapeutics Corporation |
240.97m |
3.92 |
2.08% |
0.00 |
(2,543.74%) |
— |
— |
| LCTX |
Lineage Cell Therapeutics, Inc. |
239.71m |
1.03 |
8.42% |
0.00 |
(246.58%) |
19.87% |
— |
| CUE |
Cue Biopharma, Inc. |
238.64m |
31.41 |
(4.38%) |
0.00 |
(435.83%) |
354.37% |
— |
| NAGE |
Niagen Bioscience, Inc. |
238.17m |
3.05 |
1.00% |
15.20 |
12.39% |
10.99% |
— |
| PRQR |
ProQR Therapeutics N.V. |
236.13m |
1.65 |
(3.51%) |
0.00 |
(228.71%) |
19.72% |
— |
| RNAC |
Cartesian Therapeutics, Inc. |
230.55m |
7.41 |
(2.76%) |
0.00 |
0.00% |
(94.81%) |
— |
| KROS |
Keros Therapeutics, Inc. |
229.00m |
11.62 |
1.13% |
0.00 |
0.00% |
(84.55%) |
— |
| ELDN |
Eledon Pharmaceuticals, Inc. |
228.34m |
2.65 |
(0.75%) |
0.00 |
0.00% |
— |
— |
| CGEN |
Compugen Ltd. |
224.51m |
2.38 |
0.42% |
6.26 |
47.55% |
234.18% |
— |
| PLX |
Protalix BioTherapeutics, Inc. |
221.57m |
2.72 |
(1.09%) |
11.33 |
23.50% |
30.14% |
— |
| WHWK |
Whitehawk Therapeutics, Inc. |
220.05m |
3.74 |
(2.85%) |
0.00 |
0.00% |
16.51% |
— |
| VRXA |
Veraxa Biotech AG |
217.00m |
1.41 |
0.00% |
— |
— |
— |
— |
| AVXL |
Anavex Life Sciences Corp. |
216.91m |
2.38 |
1.71% |
0.00 |
0.00% |
— |
— |
| ALEC |
Alector, Inc. |
214.38m |
1.95 |
1.56% |
0.00 |
(850.13%) |
(82.91%) |
— |
| FHTX |
Foghorn Therapeutics Inc. |
213.79m |
3.50 |
(2.78%) |
0.00 |
(175.78%) |
51.98% |
— |
| CMPX |
Compass Therapeutics, Inc. |
205.30m |
1.13 |
(0.88%) |
0.00 |
0.00% |
— |
— |
| NKTX |
Nkarta, Inc. |
204.13m |
2.75 |
(3.51%) |
0.00 |
0.00% |
— |
— |
| ADAG |
Adagene Inc. Sponsored ADR |
200.08m |
2.93 |
(1.68%) |
0.00 |
— |
— |
— |
| BCYC |
Bicycle Therapeutics PLC Sponsored ADR |
199.41m |
3.69 |
(1.07%) |
0.00 |
(311.11%) |
217.44% |
— |
| ORMP |
Oramed Pharmaceuticals Inc. |
199.25m |
4.73 |
(1.25%) |
1.12 |
0.00% |
347.77% |
— |
| SLGL |
Sol-Gel Technologies Ltd. |
198.86m |
66.85 |
10.06% |
0.00 |
(910.14%) |
(92.50%) |
— |
| TARA |
Protara Therapeutics, Inc. |
197.97m |
3.28 |
(2.09%) |
0.00 |
0.00% |
— |
— |
| CNTN |
Canton Strategic Holdings, Inc. |
191.23m |
2.57 |
11.69% |
13.67 |
0.00% |
— |
— |
| IPHA |
Innate Pharma S.A. Sponsored ADR |
188.77m |
1.70 |
0.00% |
0.00 |
(99.70%) |
(4.17%) |
— |
| ALXO |
ALX Oncology Holdings Inc. |
187.37m |
1.31 |
(3.68%) |
0.00 |
0.00% |
— |
— |
| ACOG |
Alpha Cognition Inc. |
186.64m |
8.47 |
(1.17%) |
0.00 |
(137.69%) |
— |
— |
| PEPG |
PepGen, Inc. |
185.62m |
2.59 |
(3.36%) |
0.00 |
0.00% |
— |
— |
| MSLE |
Satellos Bioscience Inc. |
184.83m |
8.70 |
(0.11%) |
0.00 |
0.00% |
— |
— |
| ANTX |
AN2 Therapeutics, Inc. |
184.53m |
4.88 |
(0.20%) |
0.00 |
0.00% |
— |
— |
| CHRS |
Coherus Oncology, Inc. |
183.86m |
1.13 |
(3.42%) |
0.00 |
(259.41%) |
61.00% |
— |
| MDWD |
MediWound Ltd. |
178.55m |
13.84 |
0.14% |
0.00 |
(170.10%) |
(40.26%) |
— |